HW201877 enantiomer

Overview

HW201877 enantiomer is the enantiomer of HW201877 ( HY-174990 ) and is 15-hydroxyprostaglandin dehydrogenase ( 15-PGDH ) inhibitor with an IC 50 of 12.2 nM. HW201877 enantiomer can be used for the research of inflammatory bowel disease, idiopathic pulmonary fibrosis, ulcerative colitis, and Crohn's disease.

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Peptic Ulcer Disease | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Crohn's Disease | Products > Disease Areas > Inflammatory Bowel Disease | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Ulcerative Colitis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Drug Isomer | Products > Signaling Pathways > 15-PGDH

Product Information

• Catalog No.: HY-174990A
• CAS No.: 2927452-82-0
• Molecular Formula: C22H22F2N6O2
• Molecular Weight: 440.45
• Purity: 97.00%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source